US BANCORP \DE\ - ARCTURUS THERAPEUTICS HLDGS ownership

ARCTURUS THERAPEUTICS HLDGS's ticker is ARCT and the CUSIP is 03969T109. A total of 127 filers reported holding ARCTURUS THERAPEUTICS HLDGS in Q1 2023. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of ARCTURUS THERAPEUTICS HLDGS
ValueSharesWeighting
Q3 2023$30,302
-14.3%
1,186
-3.8%
0.00%
Q2 2023$35,363
+14.6%
1,233
-4.2%
0.00%
Q1 2023$30,849
+44.2%
1,287
+2.1%
0.00%
Q4 2022$21,387
+94.4%
1,261
+68.6%
0.00%
Q3 2022$11,000
-21.4%
748
-13.6%
0.00%
Q2 2022$14,000
-68.2%
866
-47.3%
0.00%
Q1 2022$44,000
-22.8%
1,642
+8.0%
0.00%
Q4 2021$57,000
-1.7%
1,521
+25.9%
0.00%
Q3 2021$58,000
-10.8%
1,208
-37.1%
0.00%
Q2 2021$65,000
-11.0%
1,922
+8.6%
0.00%
Q1 2021$73,000
+265.0%
1,770
+276.6%
0.00%
Q4 2020$20,000
-25.9%
470
-24.8%
0.00%
Q3 2020$27,000
-6.9%
6250.0%0.00%
Q2 2020$29,000
+262.5%
6250.0%0.00%
Q1 2020$8,000
+14.3%
6250.0%0.00%
Q4 2019$7,000
+16.7%
6250.0%0.00%
Q3 2019$6,0000.0%6250.0%0.00%
Q2 2019$6,0006250.00%
Other shareholders
ARCTURUS THERAPEUTICS HLDGS shareholders Q1 2023
NameSharesValueWeighting ↓
Tri Locum Partners LP 208,886$5,337,0371.71%
Portolan Capital Management 276,505$7,064,7030.66%
Nikko Asset Management Americas, Inc. 1,388,574$35,422,5230.42%
Green Alpha Advisors, LLC 21,538$550,2960.42%
SummerHaven Investment Management, LLC 22,326$570,4290.42%
ARK Investment Management 1,901,546$48,584,5080.37%
Granahan Investment Management 398,862$10,190,9240.36%
FEDERATED HERMES, INC. 4,711,512$120,379,1320.32%
Woodline Partners LP 1,069,814$27,333,7480.32%
Diametric Capital, LP 26,130$667,6210.28%
View complete list of ARCTURUS THERAPEUTICS HLDGS shareholders